Page 13 - Alkermes News Today

The controlled release drug delivery market size is anticipated to grow from USD 47.97 Billion in 2022 to USD 108.45 Billion in 10 years at a CAGR of 8.5%....

Corporate Governance at Alkermes

/PRNewswire/ -- Institute for Supply Management® announced its finalist shortlist for the ISM Supply Chain Trailblazer Awards, which recognizes organizational...

In this piece, we will take a look at the 11 most promising psychedelic stocks according to hedge funds. If you want to skip our overview of the psychedelic industry and the latest news, then you can take a look at the 5 Most Promising Psychedelic Stocks. The ability to use chemicals to alter one’s […]

In this piece, we will take a look at the 11 most promising psychedelic stocks according to hedge funds.

NORTHAMPTON, MA / ACCESSWIRE / December 20, 2023 / AlkermesOriginally published in Alkermes September 2023 Corporate Responsibility ReportBoard of DirectorsOur Board is currently comprised of eleven members, each of whom has a term expiring at the Company's 2024 annual general meeting of shareholders.Board Declassif...

Alkermes Commitment to Integrity and Compliance

NORTHAMPTON, MA / ACCESSWIRE / December 18, 2023 / AlkermesOriginally published in Alkermes September 2023 Corporate Responsibility ReportEthics and ComplianceIntegrity is a core Alkermes value and the foundation of the way we do business. Alkermes is dedicated to upholding legal, regulatory and ethical standards in...

The best news, analysis and comment from The Irish Times business desk

Pharmaceutical giant Alkermes has announced that it plans to sell its Athlone facility to Danish healthcare company Novo Nordisk.